FindTrial
Sign In

Terminal branches portal vein embolization in planned major hepatectomy for hepatocellular carcinoma

Terminal branches portal vein embolization in planned major hepatectomy for hepatocellular carcinoma

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400094493
Enrollment
Unknown
Registered
2024-12-24
Start date
2024-08-01
Completion date
Unknown
Last updated
2025-01-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hepatocellular carcinoma

Interventions

TBPVE group:None

Sponsors

Yuebei People’s Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: (1) Male or female, 18 years <=age<=70 years; (2) Meet the diagnostic criteria of the Guidelines for the Diagnosis and Treatment of Primary Liver Cancer (2024 Edition); (3) Regular follow-up, complete clinical and follow-up data.

Exclusion criteria

Exclusion criteria: (1) Suffering from other malignant tumor diseases; (2) Pregnancy or lactation; (3) Severe heart, lung and other underlying diseases.

Design outcomes

Primary

MeasureTime frame
Operation time;Intraoperative blood loss;Intraoperative hospital stay;3 or 5 year survival rate;—

Countries

China

Contacts

Public ContactWenying Liu

Yuebei People’s Hospital

liuwy_dr@163.com+86 13726558869

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026